Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 2

Federal regulations

Agency
  • DOC231
  • DOT212
  • SEC
201
  • HHS185
  • FDA159
  • DOE146
  • DHS142
  • FERC130
  • FAA96
  • EPA83
  • NOAA76
  • NIH53
  • DOJ51
  • Treasury50
  • USDA47
  • DOL38
  • FCC25
  • SBA23
  • CMS18
  • IRS18
  • HUD17
  • FTC5
  • Topic
    • Compliance11
    • Operations4
    • Finance3
    • Government Relations2
    • Tax2
    • Administration1
    • Grant Management1
    • Legal1
    • Marketing1
    • Product Strategy1
    Recency
    • Last 30 days
    • Last 7 days
    HHSRemove filter: HHSIRSRemove filter: IRSClear all
    • Masuu Global Solutions LLC, U.S. Agent for Extrovis AG, et al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications; Correction
      June 16, 2026

      FDA corrects withdrawal of approval for 11 abbreviated new drug applications; Masuu Global Solutions LLC's propranolol and lidocaine ANDAs remain approved as of March 23, 2026.

    • Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
      June 16, 2026

      Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.

    • Center for Scientific Review; Notice of Closed Meetings
      June 16, 2026

      Center for Scientific Review will hold closed meetings to review grant applications and personnel matters; specific dates and locations available upon request to the designated agency contact.

    • Agency Information Collection Request; 30-Day Public Comment Request
      June 16, 2026

      HHS Office of the Secretary seeks public comments on an Information Collection Request through OMB review; the 30-day comment period is open now.

    • Agency Information Collection Activities: Submission for OMB Review; Comment Request
      June 16, 2026

      CMS is soliciting public comments on proposed information collection activities under the Paperwork Reduction Act; interested parties may submit feedback on burden estimates and collection methodology.

    • Announcement of Solicitation of Written Comments on Proposed Healthy People 2030 Objectives and Request for Information on Screen Time To Inform Healthy People
      June 16, 2026

      HHS Office of Disease Prevention and Health Promotion solicits public comments on proposed Healthy People 2030 objectives and screen time measures to inform national health goals.

    • Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
      June 16, 2026

      NIH submits its Extramural Harassment Web Form for OMB review under the Paperwork Reduction Act, with a 30-day public comment period.

    • National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting
      June 15, 2026

      National Institute of Diabetes and Digestive and Kidney Diseases announces an amended meeting notice for its advisory council to discuss research priorities and funding initiatives affecting small biotech and life-sciences firms.

    • Center for Scientific Review; Amended Notice of Meeting
      June 15, 2026

      Center for Scientific Review announces amended open meeting schedule to discuss peer review processes and grant evaluation procedures for National Institutes of Health funding cycles.

    • Government Owned Inventions Available for License: Fluorophthalimides as Anti-Inflammatory Agents for Systemic and Neurodegenerative Disorders
      June 15, 2026

      National Institute on Aging offers licensing opportunities for fluorophthalimide compounds in development as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.

    PreviousPage 2 of 21 (202 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Alabama
    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Kentucky
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants